Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.0
Journals
JCM
Special Issues
Advances in the Clinical Management of Patients Undergoing Nephrectomy: 2nd...
share announcement

Advances in the Clinical Management of Patients Undergoing Nephrectomy: 2nd Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 979

Special Issue Editor

Dr. Mihai Dorin Vartolomei

E-Mail Website
Guest Editor
Urology Department, Medical University of Vienna, Vienna, Austria
Interests: uro-oncology; cancer biology; treatment response; biomarkers and cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It was a pleasure to collaborate as a Guest Editor on the Special Issue “Advances in Clinical Management of Patients Undergoing Nephrectomy” for the Journal of Clinical Medicine, which published four feature papers (https://mdpi.longhoe.net/journal/jcm/special_issues/Clinical_Nephrectomy). We are launching a second edition of the Special Issue, titled “Advances in Clinical Management of Patients Undergoing Nephrectomy—Series 2”.

I invite you to be part of this Special Issue of the Journal of Clinical Medicine that focuses on advances in the treatment, management, and support of patients with renal cancer undergoing nephrectomy.

For this Special Issue, potential topics include (but are not limited to):

  • Advances in minimally invasive techniques of nephrectomy;
  • Advances in the clinical management of patients undergoing nephrectomy;
  • Psychological distress related to nephrectomy;
  • Nephrectomy approach and related outcomes;
  • Advances in robotic nephrectomy;
  • Personalized treatment approaches in renal cancer;
  • Machine learning and nephrectomy;
  • Artificial intelligence and nephrectomy;
  • Biomarkers and impacts on outcomes after nephrectomy;
  • Patient care and support before and after nephrectomy.

In light of these new advancements and needs, we are prioritizing high-quality original studies but also welcome well-designed meta-analyses and reviews. We look forward to your contributions.

Dr. Mihai Dorin Vartolomei
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nephrectomy
  • clinical management
  • minimally invasive techniques
  • clinical and oncological outcomes
  • personalized treatment

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

10 pages, 228 KiB  
Article
Surgical Outcomes of Hugo™ RAS Robot-Assisted Partial Nephrectomy for Cystic Renal Masses: Technique and Initial Experience
by Francesco Prata, Andrea Iannuzzi, Francesco Tedesco, Alberto Ragusa, Angelo Civitella, Matteo Pira, Marco Fantozzi, Leonilde Sica, Roberto Mario Scarpa and Rocco Papalia
J. Clin. Med. 2024, 13(12), 3595; https://doi.org/10.3390/jcm13123595 - 19 Jun 2024
Viewed by 371
Abstract
Background: The Hugo™ Robot-Assisted Surgery (RAS) system is a new cutting-edge robotic platform designed for clinical applications. Nevertheless, its application for cystic renal tumors has not yet been thoroughly investigated. In this context, we present an initial series of Robot-Assisted Partial Nephrectomy [...] Read more.
Background: The Hugo™ Robot-Assisted Surgery (RAS) system is a new cutting-edge robotic platform designed for clinical applications. Nevertheless, its application for cystic renal tumors has not yet been thoroughly investigated. In this context, we present an initial series of Robot-Assisted Partial Nephrectomy (RAPN) procedures carried out using the Hugo™ RAS system for cystic renal masses. Methods: Between October 2022 and January 2024, twenty-seven RAPN procedures for renal tumors were performed at Fondazione Policlinico Universitario Campus Bio-Medico. Our prospective board-approved dataset was queried for “cystic features” (n = 12). Perioperative data were collected. The eGFR was calculated according to the CKD-EPI formula. Post-operative complications were reported according to the Clavien–Dindo classification. Computed tomography (CT) scans for follow-up were performed according to the EAU guidelines. Trifecta was defined as the coexistence of negative surgical margin status, no Clavien–Dindo grade ≥ 3 complications, and eGFR decline ≤ 30%. Results: All the patients successfully underwent RAPN without the need for conversion or additional port placement. The median docking and console time were 5.5 (IQR, 4–6) and 79.5 min (IQR, 58–91 min), respectively. No intraoperative complications occurred, as well as clashes between instruments or with the bedside assistant. Two minor postoperative complications were recorded (Clavien–Dindo II). At discharge, serum creatinine and eGFR were comparable to preoperative values. Only one patient (8.4%) displayed positive surgical margins. The rate of trifecta achievement was 91.7%. Conclusions: RAPN for cystic renal masses using the novel Hugo™ RAS system can be safely and effectively performed. This robotic system provided satisfactory peri-operative outcomes, preserving renal function and displaying low postoperative complications and a high trifecta rate achievement. Full article
(This article belongs to the Special Issue Advances in the Clinical Management of Patients Undergoing Nephrectomy: 2nd Edition)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop